Speaker illustration

Doctor Doreen Tan

National University of Singapore, Singapore (Singapore)

Member of:

European Society of Cardiology

Doreen is currently a fulltime Associate Professor with NUS Department of Pharmacy and Cardiology Specialist Pharmacist practicing at the National University Heart Center, Singapore. She is active with practice and precision medicine research and is the Pharmacist lead for the national AMI-HOPE (Acute Myocardial Infarction allied Health-Oriented Patient-centered digitally-Enabled care) program, a digital-based post-myocardial infarction care program delivered by specialty-trained collaborative prescriber Pharmacists. She is an appointed member of the National University Health System’s Steering Committee for Pharmacogenomics. She has authored a number of publications in the subject area of cardiovascular pharmacotherapy and pharmacogenomics, and was part of the expert panel for the ACE Appropriate Care Guidelines for Hyperlipidaemia and the most recent “Strategies to prevent cardiovascular disease in Singapore: A call to action" published in the Annals Acad Med in Jan 2024.

iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Pharmacogenomics, cardio-omics, and cardiovascular drugs

Thumbnail

Myotropic drugs

Event: ESC Congress 2024

Topic: Cardiovascular Pharmacotherapy

Session: Emerging cardiovascular drugs: watch this space

Thumbnail